Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy (Q34447829)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

author name string

Minoru Miyashita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kentaro Tamaki

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Monica Chan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Hisashi Hirakawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Akihiko Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Go Watanabe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Noriko Nemoto

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Saki Nakagawa

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Takanori Ishida

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Noriaki Ohuchi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

0 references

publication date

14 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

148

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

525-534

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25395319%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Proliferation marker Ki-67 in early breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Basal-like breast cancer: a critical review

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3197-Y

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34447829&oldid=2196640858"